BrainsWay Third Quarter 2024 Earnings: EPS: US$0.02 (vs US$0.01 loss in 3Q 2023)

Simply Wall St

November 16, 2024

BrainsWay (TLV:BWAY) Third Quarter 2024 Results

Key Financial Results

Revenue: US$10.5m (up 27% from 3Q 2023).
Net income: US$662.0k (up from US$230.0k loss in 3Q 2023).
Profit margin: 6.3% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue.
EPS: US$0.02 (up from US$0.01 loss in 3Q 2023).

earnings-and-revenue-growth — TASE:BWAY Earnings and Revenue Growth November 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

BrainsWay Earnings Insights

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Medical Equipment industry in Asia.

Performance of the market in Israel.

The company's shares are down 12% from a week ago.

Risk Analysis

Be aware that BrainsWay is showing 2 warning signs in our investment analysis that you should know about...

Valuation is complex, but we're here to simplify it.

Discover if BrainsWay might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.